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EXECUTIVE SUMMARY 
The Southeaa tern Massachusetts Health Study (SMIIS) was 
conducted by investigators from the Massachusetts Department of 
Public Health to determine if communities near the Pilgrim nuclear 
power plant in Plymouth, Massachueetts had elevated leukemia 
mortality rates associated with radioactive plant discharges, The 
final report, released to the public in October 1990, found a two 
to four fold increase in the risk of leukemia among residents of 
certain towns within a 20 mile radius from the plant. A review 
committee of six public health professionals with expertise in the 
design and conduct of epidemiologic studies, the epidemiology of 
leukemia, and radiation physics,'was jointly appointed by the State 
Health Department and the Baston Edison Company in the summer of 
1991. The committee was asked to review the studyre design and 
implementation, critique its findings, and interpret the findings 
in light of existing knowledge concerning the health effects of 
ionizing radiation. The committee requested additional information 
from the SMHS investigators and this was factored into its 
deliberations. This report presents the opinions of the review 
committee. The committee's conclusion8 are as follows: 
1. The study team adhered to generally accepted 
epidemiologic principles of study design, data collection 
and data analysis, 
Potential problems that may have affected the results of 
the study were identified in three general areas: the 
method used to identify the leukemia cases; the selection 
of the subjects who served as controls; and the methods 
used to determine the study subject's exposure to 
ionizing radiation. The exact impact of these potential 
problems on the study's conclusions was difficult to 
estimate. 
The review committee used information from several expert 
bodies about the amount of radiation required to cause 
leukemia and estimates of the radiation exposure to the 
people living within 20 miles of the Pilgrim plant, to 
evaluate the biological plausibility of the study'e 
findings, The committee determined that the study's 
estimate of the number of excess leukemia deaths, over a 
ten year time period was approximately 90 times greater 
than that predicted by' data from other radiation studies. 
The leukemia mortality rates for this area have remained 
close to the state average throughout the period. This 
finding contradicts the substantial increase in leukemia 
risk found by SMSII. The committee was, therefore, 
concerned about the biological plausibility of the 
study's findings. i he strength of the association 
between leukemia and proximity to the pilgrim power plant 
was unexpected based on grevious studies of the 
leukemoger~ic effects of low dose radiation. Furthermore 
the specific problems.mentioned above make it difficult 
to corlclude that the observed association is real and 
related to nuclear power plant emissions. 
However, there have been other reports of observed cancer 
increases that are inconsistent: with predictions based on 
mathematical modeling or radiobiology theory. Because 
the findings of the SMSH cannot be readily dismissed on 
t h e  basis of methodol'ogical errors or proven biases, 
further attention to .the possible unusual pattern of 
leukemia in the region may be warranted. 
4. The review c o n i n l i t t e e  recommends tirat additional research 
be considered that addresses numerous questions raised by 
this .report. Specifically a new study should: 
A .  1ncl.ude the Cape Cod towns that were excluded 
by the original study. 
B .  ~ n c l u d e  cases of childhood leukemia, 
C .  E s t a b l i s h  a uniform s y s t e m  of case finding. 
D. ~ x t e n d  t h e  t h e  period o f  t h e  study and 
c o n s i d e r  including population8 living around 
other nuclear power plants in the New England 
area. 
E. Consider alternative radiation expoaure 
estimation models, 
F. Form an independent advisory committee that 
includes both scientists a11d citizens. 
Introduction 
The Southeastern Massachusetts Health Study represents an 
ambitious effort by investigators fromthe Massachusetts Department 
of Public Health Environmental Epidemiology (MDPH) group to address 
an important concern, namely, whether residents of certain 
communities proximal to the Pilgrim nuclear power plant had an 
increased risk of leukemia possibly associated with radioactive 
discharges from the plant. The investigators designed, conducted 
and analyzed a complex study in a very short time and with limited 
resources. A preliminary analysis of this study was completed in 
early 1990. 
Because of the state health officials concern about the 
association found by the study, in early 1990, the MDPH 
investigators invited four outside experts (Drs Cobb, Hoffman, Lyon 
and Sandler) with expertise in the epidemiology of leukemia to 
evaluate the study design for any flaws, and to recommend further 
analyses that might be performed. Three of the four advisers (Dr 
Cobb excepted) had not been involved with the development of study 
design and protocol, the phase of an epidemiologic study where 
expert review and critique are especiallyimportant and helpful to 
the investigators. This meant that three of the external advisers 
could only comment about decisions affecting study design and data 
collection that had already been made and implemented. 
This committee met with the MDPH investigators on June 25, 
1990, and reviewed the study design, data collection methods, and 
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preliminary analysis of the data. (Their recommendations to the 
MDPH investigators are attached in Appendix 1.) 
The MDPH staff prepared additional analyses at the request of 
the advisory committee and replied to some of the committee's 
recommendations. Unfortunately the final report was released to 
the public in October 1990 before all the committee's 
recommendations were addressed, and before the changes to the final 
report could be reviewed by these external advisers. 
After the release of the study findings the Boston Edison 
Company requested that a review committee be jointly appointed, 
three members to be nominated .by the Boston Edison Company and 
three by the Massachusetts Department of Public Health. This 
committee's charge was to review the study's design and 
implementation, critique its findings, and interpret these findings 
in the context of the larger body of knowledge concerning the 
health effects of exposure to ionizing radiation. The MDPH 
accepted this proposal and a six member review committee was 
constituted. The MDPH nominated three of the four members who had 
served on its earlier advisory committee, and the Boston Edison 
Company nominated three individuals affiliated with academic 
institutions in Massachusetts. All committee members agreed to 
serve without any compensation (except for travel expenses). 
The review committee met for the first time on July 8, 1991, 
to be given its charge, and to discuss the study. The attached 
letter, contained in Appendix 2, summarizing the review committee's 
recommendations at the conclusion of this meeting, contains many of 
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the same recommendations made by the earlier advisory committee at 
the June 25, 1990, meeting (See Appendix 1). 
Additional data responding to some of the 1990 advisor's 
committee and 1991 review committee requests were provided by the 
staff of the MDPH in November 1991, and February and July 1992. 
The committee held a public hearing in Boston on Friday, June 26, 
1992, and has also received and reviewed written material submitted 
by interested citizens and other groups. On the basis of all the 
information provided us, we have reached the consensus presented in 
this report. 
COMMITTEE FINDINGS 
The MDPH investigators adhered to generally accepted 
epidemiologic principles of study design, participant selection, 
data collection and analysis. They did, however, experience 
problems in case ascertainment, control selection, and exposure 
ascertainment. It is difficult to determine, retrospectively, the 
specific impact of these problems. Nevertheless, the committee 
considered problems that might' have led to a spurious positive 
association between adult leukemia and residence near the Pilgrim 
nuclear power plant. These included: 
1. The selection of the specific townships and individuals 
included in the study. 
2. The possibility of enhanced ascertainment of leukemia 
cases in areas closer to Pilgrim Station. 
3. The method of selection of controls. 
4 .  The method of exposure classification. 
The committee also considered the study findings in the 
context of other such studies that have examined the health effects 
of exposure to ionizing radiation. A more detailed consideration 
of these potential problems is presented below. 
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1. Study Populations 
A. Exclusion of Cape Cod Towns 
The committee believes that all towns within the 20-mile 
radius, including those on Cape Cod, should have been studied. 
That the Health Commissioner, at the time of the study's inception, 
did not grant approval for this additional effort is extremely 
unfortunate. These towns should be included in any new study. 
The supplemental report of the MDPH (November 21, 1991) 
presents certain ecological, or group, comparisons that imply that 
the effect of the exclusion of these towns would not be large. The 
committee, however, had difficulty determining precisely how these 
group effects would apply to individual cases and controls; this 
problem is acknowledged by the MDPH authors in the supplemental 
report. If a new study is undertaken, it should be designed to 
collect primary information from all residents of a carefully 
defined population based exclusively on geographic considerations. 
B. Exclusion of Children 
The MDPH researchers did not include children in the original 
study due to the small number of cases of childhood leukemia 
expected during the study period. While the committee does not 
view their omission as a flaw that compromised the study's internal 
validity, there was complete agreement that, given their known 
susceptibility to ionizing radiation, the inclusion of children 
would have provided additional useful information about any 
possible leukemia risk associated with the Pilgrim plant. 
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C. The exclusion of cases of chronic lymphocytic leukemia 
(CU) 
Cases of CLL were excluded from the analysis, and this 
decision was based on the known difficulty of ascertaining newly 
diagnosed CLL cases. The committee acknowledges this difficulty, 
nevertheless, a new study should consider a more extensive case 
finding mechanism that might include cases of chronic lymphocytic 
leukemia because of the additional knowledge that may be 
contributed. 
2. Cases Studied 
A. Case Ascertainment 
Eligible cases for this study were identified from area 
hospitals as well as fromthe Massachusetts Cancer Registry (MCR). 
Leukemia cases of age 13 and older at diagnosis whose dates of 
diagnosis were between 1978-1986 were included in the study. 
Because some hospitals would not cooperate by reporting cases to 
the investigators that were already reported to the MCR, the 
investigators had to rely exclusively on the MCR for some 
geographic areas. While this mixed-mode ascertainment was 
reasonable, the possibility. of biased case-finding and case- 
reporting to the MCR exists. ' It is possible that the case 
reporting to the MCR was more complete in toms closer to Pilgrim 
Station, because of community concerns about the health risk 
associated with living near the plant, or that cases farther from 
the Pilgrim plant were diagnosed in hospitals well outside the 
region. If this differential reporting occurred the result would 
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be an overestimation of risk associated with residence close to the 
power plant. 
B. Missed Cases 
In response to the review committee's request, the MDPH 
reviewedvital records and identified an additional 48 subjects who 
potentially qualified for the study but were not included. The 
committee considered this evidence of underascertainment of cases 
to be important. The committee requested additional information 
about these cases, including diagnosis listed on the death 
certificate, age, date and residence at death. It was reported 
that 14 of these would not have'qualified because they had chronic 
lymphocytic leukemia (CLL) or were diagnosed outside the period of 
interest. 
Using the more detailed data provided to the review committee 
by Dr Martha Morris, in her memorandum dated July 1, 1992, and the 
data in Table 35 of the original report, the following unmatched 
odds ratios were calculated. 
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Table 1. Comparison of the original odds ratios, and the new odds 
ratios after the additional 34 cases are added to the original 105 
cases. (The odds ratios are calculated assuming that any new 
controls selected for the 34, new cases would have had the same 
geographic distribution as the cases.) 
Original Odds Ratios (See Table 35) 
DISTANCE CASES CONTROLS O D D S  R A T I O S  
New Odds Ratios Based on the Original Plus the 34 Newly 
Identified Cases. 
DISTANCE CASES CONTROLS l 0 D D S R A T I O S  
.................................................................. 
------------------------------------------------------------------ 
Based on these data it appears that the failure to ascertain 
the 34 potential leukemias did not substantively affect the study's 
conclusions. 
C. Case Distribution by Cell Type. 
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In response to another request by the committee, the MDPH 
report presented data indicating that potential exposure was 
inversely related to chronic myelogenous leukemia (CML); while the 
numbers are relatively small and the committee does not feel that 
this af fects the conclusions about other cell types, it is noted as 
a curious observation. 
Prom data presented in Table 4 of the MDPH report it is noted 
that there is a greater proportion of chronic lymphocytic leukemia 
(CLL) cases, a cancer not usually believed to vary with ionizing 
radiation exposure, in the 22.towns studied than in the SEER 
(Surveillance, Epidemiology 'and End Results program of the U . S . 
National Cancer Institute) populations (40% vs. 34.9% among males; 
40% vs-29.7% among females). The reasons for this excess are not 
clear, but may be related to the more intense case ascertainment 
employed by the study or to differential reporting of this disease 
in the study area. It is difficult to reliably identify new cases 
of CLL but this excess might also point to some other cause of 
leukemia operating in this area.. 
3. Control Selection 
It is important to control for differences in socio-economic 
status in studies of leukemia because the disease incidence varies 
with socio-economic status. An additional problem in case control 
studies is that individuals of lower socio-economic status may be 
less likely than those of higher socio-economic status to 
participate in a study as controls; this could result in a biased 
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association. For example if people living in the area closest to 
the Pilgrim nuclear power plant (the area with the highest 
exposure) were of higher socio-economic status, compared to those 
living farther inland, and the proportion of eligible control 
subjects willing to participate decreased with socio-economic 
status, then the study would include fewer controls living near the 
power plant, irrespective of any untoward health effects or power 
plant exposure; this would result in a spurious positive 
association. Other examples could be constructed that would 
produce bias in a different direction. 
The report prepared by the MDPH investigators does not 
adequately account for participation by potential controls by 
distance from the plant. This makes any evaluation of potential 
bias introduced by the processes usedto select controls difficult. 
4. Exposure Assessment 
The committee recognizes the complexity of this issue and 
understands the reasons for the investigators using an exposure 
marker that accounted for subjectsr locations both at home and at 
work. The investigators chose a model that suggests that airborne 
particulate exposure decreases as the inverse of the square of the 
distance from the plant. This rule generally holds for known 
airborne particulate pollution. It was reasonable to use the rule 
for this application, but this model does have the effect of 
overemphasizing radiation exposure closer to a point source. 
While there is little monitoring information on the plant 
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emission's dose contribution to the specific areas in the region of 
interest, there are data on the radioactive material released. The 
speculation that long lived nuclides may have been released from 
plant effluent points that were not routinely monitored can be 
reasonably discounted based on the routine whole body counting of 
the plant workers. These workers are also neighbors and 
representative of the general community when they are not on duty. 
The whole body counting sensitivity is such that long lived 
radionuclides are measured at 0.1% of the permissible continuous 
body burden of the workers, 1% of the maximum continuous level for 
the general public. There was no evidence of unmonitored releases 
of radioactive material in these data. Our findings, concerning 
radiation releases, are consistent with the findings of State and 
Federal regulatory agencies throughout the same period. Had 
radiation releases of the magnitude required to produce the 
reported excess leukemia in the area surrounding the plant 
occurred, these releases also would have been detected by the large 
number of radiation monitors in use by businesses and universities 
throughout Eastern Massachusetts. After reviewing the available 
monitoring data throughout the period covered by the study, 
including a review of emissions monitoring techniques, the 
committee concluded that radiation releases from the Pilgrim plant 
were probably not significantly higher than reported. The 
committee also believes that the larger source of exposure to the 
bone marrow, the only important exposure for induction of leukemia, 
to the population living near the Pilgrim plant or anywhere would 
be the natural background radiation. 
The overall variation in total bone marrow exposure due to 
natural background radiation plus emissions from the Pilgrim plant 
are likely to be much less than a factor of two during the period 
of interest. The increased bone marrow exposure to residents of 
the study region due to the operation of the plant was likely 
comparable to the increases t'o residents of Denver, Colorado, who 
receive a higher radiation dose than residents of Boston, due to 
Denver's higher altitude. Therefore it is difficult to reconcile 
this small increase in potential radiation exposure with the 
reported large increase in leukemia risk found by the study. 
The committee was informed of an isolated elevated Cesium 137 
observation in a milk sample taken at a farm more than ten miles 
from the Pilgrim plant in .June 1982 that appeared to be 
inconsistent with plant release data. This observation was 
reviewed by the radiation safety staff for the Pilgrim plant and 
they concluded that the Cesium 137 was probably due to fallout 
radiation from open air nuclear weapons testing in China. 
The committee reviewed the more wide spread data of the 
contractor responsible for the environmental monitoring that 
resulted in this observation and found similar unexplained 
relatively isolated elevated Cesium 137 observations in monitoring 
data at other nuclear power plants during the same period. Similar 
observations were also found in U.S. Environmental Protection 
Agency monitoring data in others parts of the country, supporting 
the conclusion by the Pilgrim plant radiation safety staff that the 
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unexplained increase in Cesium 137 was probably due to radioactive 
fallout from Chinese nuclear weapons testing. 
The committee agreed that any future study should review 
emission data from Pilgrim Station with the view of developing an 
alternative exposure model. The committee recognizes that the 
available data are imperfect, nevertheless, some useful 
quantification may emerge. 
5. Coherence of the Study Findings in Relationship to Present 
Knowledge. 
A. Routinely Collected Data on Leukemia Deaths. 
At the review committee8 s request the investigators calculated 
leukemia death rates before, during, and after the study period 
(1973-1986). The leukemia mortality rates for this area have 
remained close to the state average throughout the period. This 
finding contradicts the substantial increase in leukemia risk found 
by the SMSH. Any future study will need to reconcile these 
morality rates with the study's findings. 
B. Estimating Potential Radiation Exposure to Produce the 
Excess Leukemia Found. 
For the purposes of radiation risk assessment, we usually 
extrapolate from the effects observed at high radiation doses to 
estimate the effects at low doses, but this process has many 
uncertainties. Consequently, biologic plausibility in the low dose 
range is not only uncertain, but effects in this dose range are 
very difficult to detect, if they exist, using standard 
epidemiologic techniques. A better estimate of what effects might 
occur at low dose, chronic exposures can be found in the studies of 
the US Department of Energy nuclear weapons production workers 
exposed to low cumulative radiation doses over a period of several 
years. A recent report in the Journal of the American Medical 
Association by Wing et al., (Volume 265, 1991, pages 1397-1402) 
that analyzed long term mortality data from this cohort, reported 
an increased risk of leukemia among white males that was greater 
than the risk predicted by using the linear extrapolation model. 
Similarly, a review of current studies by Wilkinson and Dreyer 
(Epidemiology 1991; 2: 305-309) found a significant summary risk 
estimate or 1.8 associated with employment in the nuclear industry. 
While no estimates of a specific radiation dose were available 
for the SMSH study there are several studies that have sufficient 
data to predict the number of new cases of leukemia that occur per 
unit of radiation exposure. Using data from these studies we 
prepared an estimate of the range of doses necessary to produce the 
effect seen by the MDPH study. These results are presented in the 
next section. 
C. Biologic Plausibility 
Epidemiologic studies have often identified exposure-disease 
relationships well before evidence of a biologically plausible 
mechanism, the work of John Snow on Cholera in 1854 being the 
classic example; nevertheless the committee was troubled by the 
lack of any evidence of exposure to the bone marrow of the 
population living in the areas surrounding the Pilgrim plant. The 
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main radiation releases were noble gases that do not enter the 
human food chain and accumulate in the human body. The 
radioiodines released by the plant, if ingested, are likely to 
deliver a very low dose of radiation to the bone marrow. The 
committee could find no other radioactive substances released by 
the Pilgrim plant that accumulate in the bone marrow, or give off 
large amounts of gamma radiation. 
There have been several recent studies suggesting that the 
leukemogenic potential of alpha irradiation may be greater than has 
been appreciated. For example Kadhim and colleagues (Nature 1992; 
355: 738-740) reported the transmission of chromosomal instability 
in progeny of alpha irradiated stem cells, suggesting that there 
may be unanticipated risks associated with alpha irradiation. 
Henshaw et al. (Lancet 1990; 1:1008-1012) and others (Peto, Nature 
1990; 345:389-391) reported unexpectedly strong correlations 
between residential exposure to radon and leukemia risk. Henshaw et 
al. noted that alpha radiation from radon is accompanied by gamma 
radiation, and that there is increased solubility of radon and 
radon daughters such as polonium in fat cells found in bone marrow. 
Both of these factors could contribute to a higher than currently 
believed bone marrow dose from alpha irradiation. 
The committee also reviewed other studies that have estimated 
radiation dose to the bone marrow sufficient to produce excess 
leukemia cases similar to the SMHS. These studies include the 
Japanese atomic bomb survivors and persons exposed to medical X- 
radiation. Data from these studies has been used to develop "data 
driven" relative risk models for radiation induced leukemias. 
These models incorporate factors for uncertainties of the data and 
predict the lifetime risk of dying of leukemia based on either a 
single or continuous exposure to a specific level of radiation. 
Such risk factors are not usually calculated until the dose exceed 
0.1 Sv (10 rem) single dose of low dose, low dose rate (low LET) 
radiation, or to a continuous lifetime exposure to 1 mSv (0.1 rem) 
per year. For example in a population of 100,000 males exposed to 
a single 10 rem exposure, 110 excess leukemia deaths would be 
expected among this cohort (90% CI= 50, 280). This is an increase 
of 15% above leukemia cases expected from all other causes in a 
group of males of this size during their lifetime (BEIR V). The 
excess for females under similar assumptions about radiation dose 
would be 80 leukemia deaths (90%.CI = 30,190), and represents 14% 
above that expected during the life of this cohort. 
Other expert bodies (UNSCEAR 1988, and ICRP 1990) have 
developed similar models using slightly different assumptions. 
Pooling these leukemia risk estimates with that from the BEIR V 
report gives an estimate of lifetime risk for leukemia mortality of 
0.0005 excess deaths for low dose, low dose rate exposure to 10 rem 
of low LET radiation. This estimate incorporates a Dose Reduction 
Effectiveness Factor of 2 for 'low dose, low dose rate radiation 
exposure. Risk estimates for other levels of radiation can be 
derived on the basis of proportionality of effect with dose, 
assuming a linear dose-response model in the low dose range. While 
this model assumes an acute one time exposure to ionizing 
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radiation, currently accepted models based on continuous, 
protracted exposures to low dose radiation, such as might have been 
the case for those living near the Pilgrim plant, predict fewer 
excess leukemia due to cell repair mechanisms after radiation 
damage. So the selection of the acute radiation coefficients to 
estimate excess deaths, may overstate the number of deaths expected 
around the Pilgrim plant. 
We applied the above risk estimates to the population covered 
by the SMHS to determine how many excess leukemia cases would be 
expected using the radiation release data reported to the U.S. 
Nuclear Regulatory Commission (NRC) by the Boston Edison Company 
for the Pilgrim plant. We recognize that there is a substantial 
amount of uncertainty about the actual radiation dose received by 
the SMSH study population, but felt these estimates were worthwhile 
to put the study in the context of other studies of leukemia 
associated with low dose radiation exposure. 
The U. S. Nuclear Regulatory Commission estimated the total 
population dose to the surrounding population from the start of the 
Pilgrim plant in 1972 to 1981 at 120 person-rems, with a 
hypothetical maximum annual individual dose of 34 millirem to those 
nearest the plant. The committee used the pooled estimate of 
lifetime leukemia risk from the BEIR V report, the UNSCEAR report 
and ICRP report, of 0.00005 excess lifetime leukemia deaths per rem 
of radiation. (This is for a one time radiation exposure and may 
overestimate the risk of subsequent leukemia from chronic low level 
exposure.) 
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We est imated t h e  population i n  t h e  22 towns around t h e  Pilgrim 
p lan t  a t  203,898 (U.S. 1980 census) and t h a t  t h e  s tudy covered t e n  
years.  The U.S. Nuclear Regulatory Commission (NRCP) est imated t h e  
hypothetical  maximum annual dose received a t  34 m i l l i r e m  during t h e  
time period when t h e  defec t ive  f u e l  rods w e r e  i n  place.  That dose 
a f fec ted  only those  l i v i n g  c lose  t o  t h e  Pilgrim p lan t ,  est imated a t  
640 people by t h e  NRCP. W e  used t h i s  value a s  t h e  upper l i m i t  of 
a r ad i a t ion  dose t h a t  might have been received, W e  a l s o  assumed 
t h e  population a t  h ighes t  r i s k  t o  be 1000 i n  number and t h a t  t h i s  
group received 34 m i l l i r e m  each year f o r  t e n  years  r a t h e r  than t h e  
four  years t h e  de fec t  f u e l  rods w e r e  a c tua l ly  i n  place.  
We assumed t h a t  t h e  population outs ide  t h e  a r e a  c l o s e s t  t o  t h e  
p lan t ,  estimated a t  202,898, received an average bone marrow dose 
from t h e  defec t ive  f u e l  rods of no more than 5 m i l l i r e m ,  and t h i s  
a l s o  occurred over 1 0  years.  We then est imated t h e  number of 
excess cases of leukemia t h a t  would have occurred, using t h e  pooled 
est imate of excess r i s k  from t h e  BEIR and UNSCEAR repor t s ,  These 
numbers a r e  given i n  Table 2. 
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TABLE 2 Estimates of Cases of Leukemia Expected among the 
Population of the 22 Town Near the Pilgrim Plant Compared to Those 
Found by the SMSH.' 
.................................................................. 
Predicted 
Dose Millirem Population Person-rem Leukemia Cases 
52 
342 
TOTAL 
Excess Leukemia Cases Divided by Predicted Excess Leukemia Cases 
47/0 .524  = 89.7 
.................................................................. 
1. The SMHS reported an excess of 47 leukemia cases. The excess 
leukemia cases predicted by the committee are based on a risk 
factor of 0.00005 excess leukemia cases per rem. 
2. The dose was multiplied by ten to take into account a ten year 
period of observation. 
3. This estimate of population-dose is much larger than that 
estimated by the NRC, and reflects a worst case scenario for 
radiation around the Pilgrim plant. 
.................................................................. 
We therefore calculated a maximum excess number of leukemia 
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cases in the area around the Pilgrim plant attributable to plant 
released radiation of 0.524 over the ten year time period. Or 
phrased another way there were at least 89.7 times more leukemia 
cases reported by the SMHS as predicted using data from the other 
radiation studies. 
The disparity between the number of excess leukemia cases 
reported by the SMHS and that predicted by other radiation studies 
was a concern to the connuittee. The committee was also concerned 
with the failure of the SMHS to document, from vital records, any 
excess leukemia deaths in the study area during the 10 years of the 
study compared to leukemia mortality in the same area before the 
Pilgrim plant opened. 
D. Time limited Association of Exposure to Leukemia 
One of the most intriguing findings of the study is the time 
limited association between distance from the plant and risk of 
leukemia. The excess of leukemia cases was found among those who 
lived near the plant when it was first put into operation, but not 
in those who moved in after the defective fuel rods were replaced 
(allowing for a lag time of five years from exposure to onset of 
disease). Most of the potential biases discussed in this report 
would have had to be present throughout the period studied, and not 
just during a certain period that corresponded with high plant 
emissions. From this perspective, the time limited association in 
the MDPH study suggests increased risk corresponding to some peak 
radiation exposure at a specific time in the past, accounting for 
the latency of the leukemia seen. But it is also possible that 
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this finding reflects a random increase in leukemia cases not 
associated with radiation, yet inadequately explained by any 
environmental factors studied in this report. 
The strength of the associationbetween leukemia and proximity 
to the Pilgrim power plant was unexpected based on previous studies 
of the leukemogenic effects of low dose radiation. Furthermore the 
specific problems mentioned above make it difficult to conclude 
that the observed association is real and related to nuclear power 
plant emissions. 
DISCUSSION AND RECOMMENDATIONS 
The SMHS Review Committee attempted to identify the strengths 
and weaknesses of this important study and to provide a basis for 
better understanding of any' potential health risks to the 
communities of Southeastern Massachusetts. While numerous 
limitations of the study were identified and explored in this 
report, the committee's statement should not be interpreted as 
suggesting that the study was undertaken in an unprofessional or 
careless manner. On the contrary, this study met several standards 
of proper epidemiology practice-and was performed in an objective 
manner, despite the limited resources and the emotional climate 
that prevailed in the potentially affected communities. 
However, the committee does not believe that the SMHS is 
neither of sufficiently unique quality or size so as to override 
the large body of scientific evidence concerning the dose-dependent 
effects of ionizing radiation. In particular the lack of 
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information on specific radiation doses to individuals (and use of 
surrogate information on distance), problems with selection of the 
cases and controls for the study, and hypothesized levels of 
radiation exposure required to have caused the observed increased 
rates of leukemia, were of concern to the committee. The 
possibility that the study's' findings may be attributed to chance 
should also be kept in mind. It has been pointed out by a group of 
highly regarded statisticians and epidemiologists that, in small or 
low power studies, a "statistically significant" result is more 
frequently generated by chance than by genuine difference in the 
risk of disease between the groups. (Peto, R. , Pike, M. C., Armitage 
P., Breslow N.E., Cox D.R., Howard S.V., Mantel, N., McPherson, V., 
Peto, J., Smith, P.G. British Journal of Cancer 1976; Volume 
34:585-612.) 
The committee, in quantitative terms where possible, examined 
each identifiable methodological problem and its likely impact on 
the study results. In the end, it was the committee's decision 
that additional extensive analyses of the current study's data 
would not serve to diminish the current controversy. 
A carefully designed new study that addresses the concerns 
expressed in this report should be able to contribute to a 
resolution of the issues that led to the initiation of the SMHS. 
If further research is pursued the Review Committee offers the 
following recommendations. 
RECOMMENDATIONS FOR ADDITIONAL RESEARCH 
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If further research of those living/working near the Pilgrim 
plant and subsequent risk of leukemia is contemplated, the 
committee offers the following suggestions. 
1. That a carefully defined study area be selected, and that this 
area includes those towns on Cape Cod that were excluded in 
the original study. 
2. Those leukemia cases occurring in children be included in the 
study, even though their numbers may be small. 
3. That a uniform system of case finding be established, and 
applied throughout the study area. The decision to include or 
exclude cases of chronic lyrnphocytic leukemia needs to be 
carefully considered before cases identification is begun. 
4. That the time period of the study be extended to include 
additional years. 
5. That a different mechanism of control selection not based on 
the vital status of the case be used. This mechanism should 
try to reconstruct the source population that gave rise to the 
cases as accurately as possible. 
6. That an independent evaluation of the potential radiation 
exposure from the Pilgrim plant, and from other sources, 
including background radiation, be used to construct the 
study's exposure measure. 
7. That other potential causes of leukemia such as chemical 
exposure be evaluated. 
8. That an independent scientific advisory committee be 
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established to review the study design and protocols before it 
is implemented. 
9. That a citizen's advisory committee also be established. This 
committee would review the study design and the study 
progress. 
10. That an expanded study area, including other nuclear power 
plants in or near Massachusetts be considered to enhance the 
power of the study to detect any associated risks. 
APPENDIX 1 
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July 25, 1990 
Need to hire an axperienoed statistical consultant to aseist with 
reviewing and implementing the aomraittee8~ reccmrmendation~, 
1) Compute and compare inaidence and mortality ratea from 1978- 
1986 in study areas. Present by age, 6w8 and cell type, w h a  
possible. Compute ina5denae/arortality ratios by yaar and 
compare w i t h  SEER data (eg., Connegtigut Cancer R e g i s t r y  
rates). Compute ratios by year, age, ssx and aell type. This 
may help to atidre88 changes in  l e u k e m i a  asaerkahent ainca 
1982 
2) Develop a table on sources of diagnoetic confinnation of 
leukemia cases, at least from 1982 onward. compare the 
distribution of these sources with those used in the 
Connecticut Cancer Registry to idsntify dif Ferenae~ if they 
exist. 
1) Analyze, through stratification, the effects of differential 
cause of death among the controls. Exclude cancers, then 
cardiovascular df~ease, then accidents t o  exmine the ef feo ts  
on the odds ratios, 
2 )  For proxy respondents, develop a table indicating among cases 
and controls, the source of proxy information (eg., spouae, 
child, etc. ) Compute point estimates of the odds ratios by 
each type as respondent. 
3)  Develop a table on the issue of control replacement, For 
example, the numbers of case-control pairs with no 
replacement, with 1 replacement, etc,, to address the 
magnitude of possible erfect of control repla~ement. 
4 )  select a sample of cases and controls residing in the study 
area in 1975-75 and validate addresses using various sourcas, 
Also, validate for the same sample, that the individuals 
actually lived in that reesidence for the claimed duration. 
1) Need to  more clearly deeine and explain how the exposure index 
was developed. 
2) Need t o  exansJ.ne the aomponents of the exposure model 
separately; eg., duration o f  rwidence independent of. 
distancre, proximity t o  the plant, an8 both factors together. 
3) Analyae tho residential exposures separately from occupational 
exposures ( i n  the ratio o f  2/3 residential, 113 occupational) . 
Also, if posefi le ,  factor i n  outdoor occupation apart from 
indoor o~cupation. 
4)  Compute eex-specific exposure-response odds ratios. 
5 )  Put radiation exposures t o  populations into anB understandable 
context. For example, the - m e e d  qamma dose to individuals 
under various condition6 (wind direction, time of year, plant 
release data, duration of residenue, etc.) 
6) Based on the estimated leukemia exaess in  your study and the 
estimated radiation doses, calculate a radiation risk esthate 
for th is  study (eg., excestr leukcuaia aase per year per rad of 
radiation). 
7 )  Need t o  quantify high, medium, and low exposure scores. Also, 
analyze exposure data using a distribution-dependant: cutpoint 
for these values. Analyze exposure-response using exposure as 
a continuous variable. 
8) conduct an analysis restricted to cages and control6 who lived 
in  the study area from 1974-75- Also select the 1973-78 period 
based on the observation that this was the time of increased 
emissions from the plant- Finally, restrict your analygis to 
persons residing i n  the area 10 years prior to diagnosis of 
leukemia. 
9 )  ~ d d  a variable to the exposure index to indicate straight-line 
distance to the seacoast. 
1) conduct a eeparate analysis by sex and age as variables in logistic regre~sion. Add matching factors for the analytic 
variables- 
2)  Analyze education separatelyas an indicator of socio-economio 
status and re-do the analyeis on this basis. 
3) Analyze risk as a function of age at first exposure. 
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4) Conduct separate analyees for caah leukemia ael l - type by sex 
and age at f*st exposure. 
5 )  Derive point estimates of the  odd^ ratio by date of df agna~is ,
by date of firat residence in the study area, an# by aotual 
year of f irat  resrfdence in the study area. 
1) Conduct a case-control study of childhood leukemia in same 
study area, going back to 1972. Collect data on paternal 
occupation. 
2) Need to collect additional data on radiation releases. 
Ideally, a dose-reconstruction ~ t u d y  should be implemented 
using data from the plant, EPA, and the NRC, along with 
meteorological data during the particular periods of interest. 
Individual dose algorithms~shoulcl be computed using the dase- 
recanstructlon data and infomation on residencies and 
activities from the case-control study. 
3) Develop a atliving at the tine a case diagnosisn control group 
to address the issue of residential history. 
PEER REVIEW COMMITTEE 
Daniel A. Hoftnan, Ph.D., chairman 
Sidney Cobb, M.D,  
Joseph L. Lyon, M , D . ,  M . P . H .  
Dale P. Sandler, Ph.D. 
APPENDIX 2 
Summary of Advisory Committee Recommendations 
July 1991 
Thursday, July 11, 1991 
Robert S. Knorr, Ph.D. 
Deputy Director 
Division of Environmental Health Assessment 
Massachusetts Department of Public Health 
7th Floor 
150 Tremont Street 
Boston, Massachusetts 02111 
Dear Bob, 
I was writing a brief report of our recommendations to you 
about further analyses of your #study, and realized that some of 
these ideas might be of immediate use to you, so I decided to send 
them along. I realize that Harris will send you written comments 
that summarize much of our conversation, but I thought these might 
be helpful also. 
The committee made recommendation for additional analyses and 
review on the following points: 
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1. Obtain leukemia mortality rates for Plymouth County, or 
each township, covering the time period before and after 
the opening of the plant. These rates will establish a 
baseline for leukemia occurrence in this area before, 
during and after exposure. Any information about cell 
and clinical type of leukemia will help. 
2. Obtain "all causes mortality rates " and numbers of deaths 
for each township in the affected area for the time 
period of the study. This data should be stratified by 
age and sex within each township. The data should also 
be divided by those towns that are on the seacoast, and 
those towns that are inland. 
We are trying to rule out a systematic bias in control 
selection. Our assumption is that the inland townships 
had a much higher all causes mortality rate than the 
seacoast towns, thus leading to a systematic bias in 
control selection. ' 
3. Using township mortality data check to see if there are 
deficits or excesses of leukemia cases in any township 
during the study period. The purpose of this exercise is 
to test the completeness of leukemia ascertainment for 
each of the townships to see if there was a systematic 
bias in case selection that might explain the findings. 
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4. Provide more detail on the confirmation of the leukemia 
cases. The leukemia cases were said to be histologically 
confirmed in 90% of the cases, but such a statement is 
too imprecise for such an important study. Is 
histologically confirmed a bone marrow diagnosis, or does 
it also include cases based on peripheral blood? For a 
densely populated state like Massachusetts, 10% of cases 
without histologic confirmation is also alarming. It 
should be more like 1-2%. What was used to make the 
diagnosis in those cases where there was no histologic 
confirmation? 
5. The data on the confirmation of addresses given by 
respondents needs to be put in tabular form, divided by 
case-control status. Since there may be more than one 
address during the exposure period the table also needs 
to show the proportion of all potential addresses 
conf irmed . 
6. The table showing the number and proportion of 
individuals who refused to participate needs to be 
divided by case-control status, and percents calculated 
for cases and controls separately. (As an addendum, it 
might be useful to also calculate a refusal rate by case 
control status for seacoast versus inland communities. 
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7. The data on smoking needs to be broken down by clinical 
and cell type, age, and pack-years smoked. The 
association has been seen in those with acute myelogenous 
leukemia, who are older, and who have accumulated a high 
number of pack-years. Odds ratios should be calculated 
for these subgroups. 
8. The occupational groupings used to define high risk needs 
to be stated explicitly. 
9. Analyses by broad categories of cell type and age at 
first exposure should .also be done. Acute versus chronic 
is the most obvious disease breakdown, and ages 13 to 44 
and 45+ are the best ages. The data on the latency 
periods of leukemia after radiation needs to be cited. 
The original paper was authored by Ichimaru and Ishimaru, 
Journal of Radiation Research, 1976, 16 (supplement):89- 
96, and was summarized by Land in Radiation 
Carcinoqenesis. E p i d e m i o l o ~ a n d B i o l o q i c a l  Simificance: 
Proqress in Cancer Research and Therapy, Volume 26, New 
York: Raven Press, 1984, see pages 421-436. Latency 
should then be examined using groups similar to the ones 
they used in the Hiroshima and Nagasaki cohorts. I have 
enclosed a figure from the article by Land that 
summarizes the different latency periods. 
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10. Dr. Masse will review the data on radioactive releases 
from the plant, the adequacy of monitoring, and amounts 
measured during the study period. He should attempt to 
reconcile this with data obtained from citizens ' groups. 
11. The exposure score should be recomputed, using the term 
for distance from the plant as linear, rather than 
squared term. Odds ratios should then be recomputed. 
12. A study of leukemia in children in the same area needs to 
be conducted immediately. 
13. The exclusion of the towns on Cape Cod needs to be 
justified. 
Best Wishes 
